Annual CAPEX
N/A
December 31, 2023
Summary
- ONCT annual capital expenditures is not available.
Performance
ONCT CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly CAPEX
N/A
September 30, 2024
Summary
- ONCT quarterly capital expenditures is not available.
Performance
ONCT Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CAPEX
N/A
September 30, 2024
Summary
- ONCT TTM capital expenditures is not available.
Performance
ONCT TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
ONCT CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
ONCT CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time |
Oncternal Therapeutics CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2011 | $54.00 K(-43.2%) | - | - |
| Jun 2011 | - | $24.00 K(+50.0%) | $50.00 K(+78.6%) |
| Mar 2011 | - | $16.00 K(+128.6%) | $28.00 K(-70.5%) |
| Dec 2010 | $95.00 K(-84.2%) | $7000.00(+133.3%) | $95.00 K(-64.3%) |
| Sep 2010 | - | $3000.00(+50.0%) | $266.00 K(-39.1%) |
| Jun 2010 | - | $2000.00(-97.6%) | $437.00 K(-25.9%) |
| Mar 2010 | - | $83.00 K(-53.4%) | $590.00 K(-1.7%) |
| Dec 2009 | $600.00 K(-79.3%) | $178.00 K(+2.3%) | $600.00 K(-2.3%) |
| Sep 2009 | - | $174.00 K(+12.3%) | $614.00 K(-38.0%) |
| Jun 2009 | - | $155.00 K(+66.7%) | $991.00 K(-56.9%) |
| Mar 2009 | - | $93.00 K(-51.6%) | $2.30 M(-20.8%) |
| Dec 2008 | $2.90 M(+67.3%) | $192.00 K(-65.2%) | $2.90 M(-18.2%) |
| Sep 2008 | - | $551.00 K(-62.4%) | $3.55 M(+7.0%) |
| Jun 2008 | - | $1.47 M(+110.2%) | $3.32 M(+46.0%) |
| Mar 2008 | - | $697.00 K(-17.0%) | $2.28 M(+31.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2007 | $1.74 M(+200.3%) | $840.00 K(+162.5%) | $1.74 M(+81.2%) |
| Sep 2007 | - | $320.00 K(-23.6%) | $958.00 K(+19.3%) |
| Jun 2007 | - | $419.00 K(+166.9%) | $803.00 K(+80.0%) |
| Mar 2007 | - | $157.00 K(+153.2%) | $446.00 K(-22.8%) |
| Dec 2006 | $578.00 K(-38.2%) | $62.00 K(-62.4%) | $578.00 K(-11.3%) |
| Sep 2006 | - | $165.00 K(+166.1%) | $652.00 K(+59.8%) |
| Jun 2006 | - | $62.00 K(-78.5%) | $408.00 K(-58.6%) |
| Mar 2006 | - | $289.00 K(+112.5%) | $986.00 K(+5.5%) |
| Dec 2005 | $935.00 K(-20.4%) | $136.00 K(-272.2%) | $935.00 K(-1.1%) |
| Sep 2005 | - | -$79.00 K(-112.3%) | $945.00 K(-23.8%) |
| Jun 2005 | - | $640.00 K(+168.9%) | $1.24 M(-7.5%) |
| Mar 2005 | - | $238.00 K(+63.0%) | $1.34 M(+14.2%) |
| Dec 2004 | $1.17 M | $146.00 K(-32.4%) | $1.17 M(+14.2%) |
| Sep 2004 | - | $216.00 K(-70.9%) | $1.03 M(+26.6%) |
| Jun 2004 | - | $741.00 K(+943.7%) | $812.00 K(+1043.7%) |
| Mar 2004 | - | $71.00 K | $71.00 K |
FAQ
- What is the all time high annual CAPEX for Oncternal Therapeutics?
- What is the all time high quarterly CAPEX for Oncternal Therapeutics?
- What is the all time high TTM CAPEX for Oncternal Therapeutics?
What is the all time high annual CAPEX for Oncternal Therapeutics?
Oncternal Therapeutics all-time high annual capital expenditures is $2.90 M
What is the all time high quarterly CAPEX for Oncternal Therapeutics?
Oncternal Therapeutics all-time high quarterly capital expenditures is $1.47 M
What is the all time high TTM CAPEX for Oncternal Therapeutics?
Oncternal Therapeutics all-time high TTM capital expenditures is $3.55 M